Los Angeles-based UCLA Health appointed Mediget Teshome, MD, chief of breast surgery and director of breast health.
The Latest
The FDA recently approved the nation's first artificial intelligence-powered medical device that detects skin cancer.
Drugmakers have their sights set on a class of cancer drugs known as antibody drug conjugates, or ADCs, to drive growth, CNBC reported Jan. 14.
The expected increase in new cancer diagnoses this year is record-setting, even as overall cancer mortality is expected to continue its decline, the American Cancer Society said in its latest report.
Substance use disorders are highly variable among cancer patient populations, and new research points to five cancers with the highest prevalence of SUDs, according to a study published Jan. 11 in JAMA.
A combination of artificial intelligence and image screening software used by a blogger allegedly found evidence of data manipulation across a range of research papers published by four experts at the Dana-Farber Cancer Institute in Boston dating back to 1997.
West Orange, N.J.-based RWJBarnabas Health has three new cancer centers under construction, including New Jersey's first freestanding cancer center.
Cancer diagnosis rates among people under 50 are on the rise. In the U.S, the rate among this group jumped nearly 13% from 2000 — when it was 95.6 cases per 100,000 people — to 107.8 by 2019. Physicians and…
An American Cancer Society study found states with expanded Medicaid status had more insurance coverage for newly diagnosed cancer patients and fewer uninsured patients.
City of Hope and Children's Oncology Group researchers conducted the largest clinical trial to date to investigate the prevention of childhood cancer survivors from developing heart failure.